Observation of Neuromuscular Block Clinical Trial
Official title:
Quantitative Assessment of Train of Four Device for Patients Receiving Neuromuscular Blockade
The assessment of neuromuscular blockage is common practice in the operating room, in which such agents are employed. Still today, the use of simple hand held stimulators and visual monitoring of these responses are the norm. The investigators want to study the potential for employing a non‐invasive quantitative device with built in sensors that will hopefully accurately determine the degree of neuromuscular blockade. This system utilizes commonly employed train of four (TOF) electrical stimulation pulses, an incorporated force sensor and an automated detection system. This system will not only utilized pre‐blockade, but also throughout an entire surgical procedure and during reversal therapy. For comparisons, the investigators will use both the prototype device and a standard hand held TOF for the assessment of neuromuscular blockage. In other words, the planned protocol will involve testing the effectiveness and accuracy of the device concurrently with peripheral nerve stimulation, during a procedure as is done for the current standard of care. All protocols will be carried out under the direct guidance and supervision of anesthesiologists and/or nurse anesthetists.
Project Summary:
In this study the investigators propose to evaluate a train of four (TOF) stimulator that
assess the neuromuscular junction of a patient under anesthesia. The goal of this project is
to evaluate a novel device in comparison to the standard of care with a hand held stimulator.
Background and Significance:
The assessment of neuromuscular blockage is common practice in the operating room, in which
such agents are employed. Still today, the use of simple hand held stimulators and visual
monitoring of these responses are the norm. The investigators now want to study the potential
for employing a non-invasive quantitative device with built in sensors that will hopefully
accurately determine the degree of neuromuscular blockade. This system utilizes commonly
employed train of four (TOF) electrical stimulation pulses, an incorporated force sensor and
an automated detection system. This system will not only utilized pre-blockade, but also
throughout an entire surgical procedure and during reversal therapy. For comparisons, we will
use both the prototype device and a standard hand held TOF for the assessment of
neuromuscular blockage.
In other words, the planned protocol will involve testing the effectiveness and accuracy of
the device concurrently with peripheral nerve stimulation, during a procedure as is done for
the current standard of care. All protocols will be carried out under the direct guidance and
supervision of anesthesiologists and/or nurse anesthetists.
The procedure involves applying the device to a suitable anatomic location for train of four
(TOF) stimulation/monitoring and then applying a small electrical pulse to stimulate the
patient's motor point. The location for this stimulation has historically been on the
patients forearm over the ulnar nerve area or on the patients face in the distribution of the
facial nerve. The stimulation applied to these areas is equivalent to that applied in the
current accepted standard of care. All responses measured by the device will be recorded
electronically and compared to anesthesiologist's/nurse anesthetist's interpretation of the
number of muscle twitches induced by peripheral motor point stimulation. These comparisons
will be analyzed for correlation between number of muscle twitches and degree of force
generation sensed by the device, with the aim of more accurately determining the degree of
the patients neuromuscular blockade.
This device application and monitoring will be carried out on anesthetized surgical patients
at different time points in the procedure, under the same conditions as the currently
utilized peripheral nerve stimulators to judge neuromuscular transmission and anesthesia
effectiveness. We will also use the system on other anatomical locations that may be easier
to gain assess to under certain surgical procedures: e.g., on the bicep, quadriceps, or
tibialis anterior muscles. Such locations have been described by anesthesiologists as viable
options.
Pre and post-surgical care will be unchanged and follow current standard of care. The only
change will be that alongside current peripheral nerve stimulation, our non-invasive TOF
device will also be utilized for assessing the relative degree of neuromuscular blockage.
Currently, there is no clinically available device that is automated and records the TOF
conducted the anesthesiologist and their staff. Developing a method for completed this
assessment is expected to save the anesthesiologist's time and prevent human error and
increase consistency.
This device and approach is similar to the muscle force system which we have employed to
study patients with neuromuscular disorders at the University of Minnesota for over 20 years.
Specific Aims/Study Objectives:
The investigators hypothesize that the use of an advance TOF device with automated data
storage and a unique user interface will demonstrate enhanced efficacy for monitoring
neuromuscular blockade in patients. The investigators will continue to recruit subjects for
this study until we have completed the study.
Research Design and Methods:
The study population will include female and male participants ranging from 18-80 years of
age. The investigators are requesting a total of 400 participants in the study. After the
investigators have collected data from these individuals they will analyze the data to
determine the efficacy of the testing method. If the initial population size is extremely
variable or does not allow the investigators to conduct a proper analysis, they will request
additional subjects to make a conclusion on this device.
Subject will be identified by the anesthesiologist prior to surgery, consent will be obtained
prior to surgical procedures. The information that will be collected from their medical
records will include their age, height, weight, history of muscular disease i.e. myotonias,
malignant hyperthermia, previous adverse reactions to anesthesia, complete anesthetic records
from procedure. Data will be securely stored and locked in Mayo B172.
Data and Safety Monitoring Plan:
It is not anticipated that the use of this device will produce any side effects or emotional
upset. The stopping rules of the study include any unexpected complications with the use of
the TOF stimulator in the OR. The patient will be unconscious or sedated during monitoring.
Statistical Considerations:
Historically, FDA clinical trials have utilized anywhere from 100-400 patients for
determining the relative safety and efficacy of a medical device or technology. The obtained
data will be analyzed to determine such factors and could be utilized for FDA approval of a
monitoring system for clinical use.
Direct comparison of the devices qualitative evaluation of scoring from the administering
anesthesiologist will be used for the final analysis.
Data and Record Keeping:
The data will be recorded by Dr. Michael Loushin, Dr. Paul Iaizzo, Dr. Jake Hutch, Tinen
Iles, the data will be stored securely in Mayo B172 or with the anesthesiologist. The data
will be stored from the automated TOF and the manual TOF performed in Mayo B172 or with the
anesthesiologist.
References:
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02100293 -
Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium
|
N/A | |
Withdrawn |
NCT01592630 -
Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections
|
Phase 3 | |
Completed |
NCT02318810 -
Influence of the Neuromuscular Blockade on Mask Ventilation
|
N/A | |
Completed |
NCT03420937 -
Deep Neuromuscular Block During General Anaesthesia in Robotic Surgery
|
Phase 4 | |
Completed |
NCT01885715 -
Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium
|
N/A | |
Completed |
NCT01318382 -
Residual Curarization and Its Incidence at Tracheal Extubation (P08194)
|
Phase 4 | |
Completed |
NCT02057861 -
Reversal of Neuromuscular Blockade in Diabetic Patients
|
N/A | |
Completed |
NCT01349751 -
Clinical Characteristics of Spinal Levobupivacaine: Hyperbaric Compared With Isobaric Solution
|
N/A | |
Completed |
NCT02825121 -
Evaluation of Monitoring Neuromuscular Blockade the Flexor Hallucis Compared to the Adductor Pollicis
|
N/A | |
Completed |
NCT02602964 -
A Trial Comparing Deep Versus Moderate Neuromuscular Block - in Low Pressure Pneumoperitoneum
|
Phase 4 | |
Completed |
NCT02126852 -
Comparison of AMG and EMG to Avoid Residual Paralysis After General Anesthesia
|
N/A |